官方服务：
资源简介：
Here we describe several SARS-CoV-2 synthetic strains that were used to develop and evaluate the single-cycle SARS-CoV-2 cocept as vaccine.
应用场景：
创建时间：
2024-07-21
相关数据集
Two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge. Sun et al
Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), this virus has spread worldwide, causing the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has result
NIAID Data Ecosystem90
DataSheet_1_Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins.pdf
Successful vaccine efforts countering the COVID-19 pandemic are centralized around the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein as viral antigen and have greatly
NIAID Data Ecosystem30
DataSheet_1_MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.pdf
To control the coronavirus disease 2019 (COVID-19) pandemic and the emergence of different variants of concern (VoCs), novel vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
NIAID Data Ecosystem20
Novavax Historical Data
Novavax has a volatile chart and while I don’t usually recommend buying stocks this big (as higher multiples limit profit), here I might make an exception. The drug maker’s shares tumbled 26.1% in the
DataCite Commons2022-10-14 更新60
DataSheet_1_Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model.docx
The newly emerged novel coronavirus, SARS-CoV-2, the causative agent of COVID-19 has proven to be a threat to the human race globally, thus, vaccine development against SARS-CoV-2 is an unmet need dri
NIAID Data Ecosystem30
